DIA
Drug Information Association Logo
« Back to Listing

Today's Dynamic Medical Science Liaison Environment

Track:
Medical Communication, Medical Writing, and Medical Science Liaison

Day & Time:
June 19, 9:00AM - 10:30AM (Pacific Standard Time)

Session Number:
404

Room Number:
7A

Level:
Basic

Type:
Session

Title:
Today's Dynamic Medical Science Liaison Environment

Chair(s):
Geoff Brockway
Director, Global MSL Excellence
AstraZeneca, United Kingdom

Description:
Medical Science Liaison (MSL) organizations continue to expand and evolve secondary to the evolving needs within the pharmaceutical industry. A changing customer base, new and expanded regulations, and the growing complexity of therapeutic agents, offer new opportunities for the continued expansion and evolution of the MSL role. Currently, MLSs are engaged in clinical trial related activities, managed care and heath economics discussions, business development projects, and other activities. In this session, a diverse group of MSL representatives will share why these roles are critical and how they contribute to the overall medical affairs objectives.

Learning Objective(s):
Discuss the critical role of the MSL; Describe the evolution of the MSL role.

Presentation(s) & Speaker(s):
Industry Perspective
David A. Jencen, PhD
Principal
Jencen Field Medical Consulting LLC, United States

Industry Perspective
Neil H. Gray
Senior Vice President, Medical Affairs
Inventiv Therapeutics Institute, United States